RxDoctor Payments Data

Arturo Rojas

Medical · Sunrise, FLNPI 1417380056

Payments from drug & device makers

$2,224in general payments, 2019–2025

Across 70 payments — averaging $31.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$1K
  • Gilead$555
  • Amgen$144
  • Lilly USA, LLC$139
  • GSK$109
  • Exact Sciences$60
  • plus $131 from 7 others

What the payments were for

  • Travel & lodging$131%
  • Food & beverage$2,21199%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,224 in reported general payments places this provider in the 70th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$1,841
Medicare patients
11
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$27,743
EntrestoSacubitril/Valsartan29$22,202
TrulicityDulaglutide22$21,156
OzempicSemaglutide11$14,853
BrilintaTicagrelor11$7,543
MyrbetriqMirabegron12$5,414
Humalog Kwikpen U-100Insulin Lispro11$1,604
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,135
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic11$837
Levothyroxine Sodium23$798
Gabapentin34$423
Memantine Hcl13$350
Famotidine19$207
Quetiapine Fumarate11$176
Atorvastatin Calcium66$149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$139$21,15622 claims
Novo NordiskOzempic$17$14,85311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,031 medical providers in Florida.

Other medical in Sunrise

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →